Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

13.45
+0.42003.22%
Post-market: 13.450.0200+0.15%16:32 EDT
Volume:990.80K
Turnover:13.20M
Market Cap:1.41B
PE:-9.29
High:13.58
Open:12.98
Low:12.61
Close:13.03
Loading ...

Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock

PR Newswire
·
02 Apr

BRIEF-Edgewise Therapeutics Announces Positive Top-Line Results From Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy

Reuters
·
02 Apr

Edgewise: Trial Showed Clinically Meaningful Reductions in Lvot Gradients in Participants With Obstructive HCM

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics Inc - Edg-7500 Was Generally Well-Tolerated

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics Announces Positive Top-Line Results From Phase 2 Cirrus-HCM Four-Week Trial of Edg-7500 in Hypertrophic Cardiomyopathy (HCM)

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics Inc: Initial Data Read-Out From Part D Is Expected in Second Half of 2025

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics Inc - Phase 3 Initiation Planned for First Half of 2026

THOMSON REUTERS
·
02 Apr

Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time

PR Newswire
·
27 Mar

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference

Business Wire
·
11 Mar

Stock Track | Edgewise Therapeutics, Inc. (EWTX) Soars 5.33% on Analyst Optimism

Stock Track
·
07 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edgewise Therapeutics (EWTX) and Walgreens Boots Alliance (WBA)

TIPRANKS
·
07 Mar

Edgewise Therapeutics initiated with an Outperform at Scotiabank

TIPRANKS
·
07 Mar

Edgewise Therapeutics: Promising Pipeline and Upcoming Data Readouts Reinforce Buy Rating

TIPRANKS
·
05 Mar

Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on March 11, 2025

Business Wire
·
04 Mar

Edgewise Therapeutics (EWTX) Gets a Buy from RBC Capital

TIPRANKS
·
04 Mar

Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI

TIPRANKS
·
04 Mar

Edgewise Therapeutics Reports 2024 Financial Results and Progress

TIPRANKS
·
04 Mar

Edgewise Therapeutics Reports Wider-Than-Expected Q4 Net Loss

MT Newswires Live
·
03 Mar

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Total Operating Expenses $45.5M

MT Newswires Live
·
03 Mar

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
03 Mar